Jan 26 (Reuters) - Trimel Pharmaceuticals Corp TRL.TO :
* Announces filing of Natesto(TM) with Health Canada
* Filed new drug submission with Health Canada for natesto nasal gel for
replacement therapy in men
* Commercial rights to natesto in United States and Mexico have been licensed
by Trimel to affiliate of Endo International PLC
* Endo intends to launch the product in the U.S., through its Endo
Pharmaceuticals subsidiary, in this first quarter of 2015
* Source text for Eikon ID:nMKW90mfFa
* Further company coverage TRL.TO ((Bengaluru Newsroom; +1 646 223 8780))